High-Throughput Hematology: How the Mindray BC-6800Plus Reshapes Lab Workflow

Mindray BC-6800Plus 5-Part Differential Hematology Analyzer

The BC-6800Plus from Mindray addresses this directly. Capable of processing up to 200 tests per hour, it is built for high-volume hospital labs and diagnostic centers where sample backlogs directly affect turnaround times. With capacity for 100 samples simultaneously, the machine sustains continuous operation without the repeated pauses for reloading that slow down lower-end systems.

Technically, it delivers a five-part white blood cell differential along with complete blood count parameters. Its SF Cube technology and fluorescent staining improve the detection of nucleated red blood cells and reticulocytes, which are critical markers in anemia and bone marrow disorders. The system also automatically calculates the neutrophil-to-lymphocyte ratio, reducing the need for manual follow-up calculations.

The automation layer is equally important. Automatic rerun and reflex testing mean the machine can re-run samples or trigger additional tests without operator intervention. In a busy lab, this removes a significant source of human error and frees technicians for higher-value tasks.

Mindray has integrated these capabilities into a platform that competes with established players from Japan and Europe, but at a price point that aligns with budget-conscious procurement. As Chinese diagnostic equipment gains traction in global tenders, the BC-6800Plus represents a calculated trade-off between advanced features and operational cost.

For labs that must balance accuracy, speed, and reagent overhead, this analyzer makes a practical case: it reduces manual steps, flags critical results earlier, and standardizes hematology workflows.

The question is no longer whether Chinese analyzers can perform, but whether traditional buyers are ready to restructure supply chains around them.

Why it matters:
For hospital administrators and lab directors, the BC-6800Plus offers a way to raise throughput without proportionally increasing staff or consumables costs. Its adoption signals a broader shift toward automated, high-speed diagnostics built on Chinese manufacturing — a trend that institutional buyers can no longer ignore.

View Product →